forked from sadicelik/DrugBank-Web-Scraper
-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathpharmaco-metabolomics-page116_markup.html
282 lines (282 loc) · 78.3 KB
/
pharmaco-metabolomics-page116_markup.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
<!DOCTYPE html><html class="turbolinks-progress-bar"><head><meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"><meta content="fdhmwDBTGwNPe0lKcJVly7AToLfZYvJ-mtjFAPTMZGs" name="google-site-verification"><meta content="296E0FF6379AE64A0D18C39BB40ECD6E" name="msvalidate.01"><title>Pharmaco-metabolomics | DrugBank Online</title><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-57x57-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-60x60-precomposed.png" sizes="60x60"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-72x72-precomposed.png" sizes="72x72"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-76x76-precomposed.png" sizes="76x76"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-114x114-precomposed.png" sizes="114x114"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-120x120-precomposed.png" sizes="120x120"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-144x144-precomposed.png" sizes="144x144"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-152x152-precomposed.png" sizes="152x152"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-180x180-precomposed.png" sizes="180x180"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon.png" sizes="57x57"><link rel="icon" type="image/png" href="/favicons/favicon-96x96.png" sizes="96x96"><link rel="icon" type="image/png" href="/favicons/favicon-32x32.png" sizes="32x32"><link rel="icon" type="image/png" href="/favicons/favicon-16x16.png" sizes="16x16"><link rel="icon" type="image/png" href="/favicons/favicon.png" sizes="16x16"><link rel="shortcut icon" type="image/x-icon" href="/favicons/favicon.ico"><meta content="#da532c" name="msapplication-TileColor"><meta content="/favicons/mstile-144x144.png" name="msapplication-TileImage"><meta content="#ffffff" name="theme-color"><meta content="DrugBank" name="application-name"><link as="font" crossorigin="" href="/assets/GemeliWeb-Regular-9ccb07b090f3aef673e3b29ba66e2e685ccf3d438e550624d9739f1bd5164cb2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Bold-f344ff98a063f8cb6ac490b132bda4035ecc8984358dfa8d9bd8621fa38744e2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Light-8227f53ee1957ae57cc0c81d1cfecb59238e3fd9d32b1e792432e1f8c81784a1.woff2" rel="preload" type="font/woff2"><link as="style" data-turbolinks-track="true" href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" onload="this.onload=null;this.rel='stylesheet'" rel="stylesheet"><noscript><link href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" rel="stylesheet" /></noscript><link rel="stylesheet" media="all" href="/assets/public-720199d14ecb75df792c22a0b89a1e5817dab39ae1fda73ea0da1c4d7f67510b.css" data-turbolinks-track="true"><script type="text/javascript" async="" src="https://www.googleadservices.com/pagead/conversion_async.js"></script><script type="text/javascript" async="" src="https://snap.licdn.com/li.lms-analytics/insight.min.js"></script><script async="" src="https://d.clarity.ms/s/0.6.27/clarity.js"></script><script src="https://js.hsadspixel.net/fb.js" type="text/javascript" id="hs-ads-pixel-2224137" data-ads-portal-id="2224137" data-ads-env="prod" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-banner.com/2224137.js" type="text/javascript" id="cookieBanner-2224137" data-cookieconsent="ignore" data-hs-ignore="true" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-analytics.net/analytics/1636199100000/2224137.js" type="text/javascript" id="hs-analytics"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script async="" src="https://www.clarity.ms/tag/5600r08mxy"></script><script src="/assets/public-27f932f135aadc4b526264005f1d5e85b32bfbdf9c790701e4b7be02cb9db204.js" media="all" data-turbolinks-track="true" defer="defer"></script><script>(function(c,l,a,r,i,t,y){
c[a]=c[a]||function(){(c[a].q=c[a].q||[]).push(arguments)};
t=l.createElement(r);t.async=1;t.src="https://www.clarity.ms/tag/"+i;
y=l.getElementsByTagName(r)[0];y.parentNode.insertBefore(t,y);
})(window, document, "clarity", "script", "5600r08mxy");</script><meta name="csrf-param" content="authenticity_token">
<meta name="csrf-token" content="8nePXorNeQY8H9sfsjZCN/BnL7hUzOHKxSIIJk2if5x0D1I5frlFan7DoLbsSNWHNHaHWWUXPvphLebm3H8FHQ=="><style>html.turbolinks-progress-bar::before {
content: '';
position: fixed;
top: 0;
left: 0;
z-index: 2000;
background-color: #0076ff;
height: 3px;
opacity: 0.99;
width: 0%;
transition: width 300ms ease-out, opacity 150ms ease-in;
transform: translate3d(0,0,0);
}</style><script async="" src="https://www.googletagmanager.com/gtag/js?id=AW-704543816"></script><script src="https://googleads.g.doubleclick.net/pagead/viewthroughconversion/704543816/?random=1636199162276&cv=9&fst=1636199162276&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=720&u_w=1280&u_ah=720&u_aw=1280&u_cd=24&u_his=100&u_tz=180&u_java=true&u_nplug=0&u_nmime=0&gtm=2oab31&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fgo.drugbank.com%2Fpharmaco%2Fmetabolomics%3Fpage%3D116&tiba=Pharmaco-metabolomics%20%7C%20DrugBank%20Online&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4"></script></head><body class="pharmaco-metabolite-regulations-c index-a has-banner"><header><nav class="navbar fixed-top navbar-expand-custom navbar-light" id="main-nav" style="background-color: #ff00b8;"><a class="navbar-brand" href="/"><img style="width: 178px; height: 20px;" src="/assets/logo-white-dd185d748ee0164b8ee8f88df29235cd8cfc7936a3c974589262c667e9294219.svg" alt="Logo white"><div class="online">Online</div></a><button aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler navbar-toggler-right" data-target="#navbar" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbar"><ul class="navbar-nav ml-auto"><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Browse</a><div class="dropdown-menu"><a class="dropdown-item" href="/drugs"><div class="icon-circle drugbank-icon icon-drugs"><svg class="icon" role="img" title="drugs">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugs"></use>
</svg>
</div> Drugs</a><a class="dropdown-item" href="/drugs/starred"><div class="icon-circle drugbank-icon icon-star"><svg class="icon" role="img" title="star">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#star"></use>
</svg>
</div> Starred Drugs</a><a class="dropdown-item" href="/categories"><div class="icon-circle drugbank-icon icon-categories"><svg class="icon" role="img" title="categories">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#categories"></use>
</svg>
</div> Categories</a><a class="dropdown-item" href="/pathways"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pathways</a><a class="dropdown-item" href="/reactions"><div class="icon-circle drugbank-icon icon-reactions"><svg class="icon" role="img" title="reactions">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#reactions"></use>
</svg>
</div> Drug Reactions</a><a class="dropdown-item" href="/classyfication"><div class="icon-circle drugbank-icon icon-classifications"><svg class="icon" role="img" title="classifications">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#classifications"></use>
</svg>
</div> Drug Classification</a><a class="dropdown-item" href="/targets"><div class="icon-circle drugbank-icon icon-targets"><svg class="icon" role="img" title="targets">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#targets"></use>
</svg>
</div> Drug Targets</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/pharmaco/genomics"><div class="icon-circle drugbank-icon icon-geno-browse"><svg class="icon" role="img" title="geno-browse">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#geno-browse"></use>
</svg>
</div> Pharmaco-genomics</a><a class="dropdown-item" href="/pharmaco/metabolomics"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Pharmaco-metabolomics</a><a class="dropdown-item" href="/pharmaco/transcriptomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-transcriptomics</a><a class="dropdown-item" href="/pharmaco/proteomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-proteomics</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">COVID-19</a><div class="dropdown-menu"><a class="dropdown-item" href="/covid-19"><div class="icon-circle drugbank-icon icon-covid-overview"><svg class="icon" role="img" title="covid-overview">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-overview"></use>
</svg>
</div> Overview</a><a class="dropdown-item" href="/covid-19-vaccination"><div class="icon-circle drugbank-icon icon-covid-vaccination"><svg class="icon" role="img" title="covid-vaccination">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-vaccination"></use>
</svg>
</div> Vaccine Side Effects</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Search</a><div class="dropdown-menu"><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/structure"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Chemical Structure</a><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/mass"><div class="icon-circle drugbank-icon icon-molecular-weight"><svg class="icon" role="img" title="molecular-weight">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#molecular-weight"></use>
</svg>
</div> Molecular Weight</a><a class="dropdown-item" href="/drug-interaction-checker"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Drug & Food Interactions</a><a class="dropdown-item" data-no-turbolink="true" href="/structures/search/bonds/sequence"><div class="icon-circle drugbank-icon icon-sequence"><svg class="icon" role="img" title="sequence">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#sequence"></use>
</svg>
</div> Target Sequences</a><a class="dropdown-item" data-no-turbolink="true" href="/pharmaco/search"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pharmaco-omics</a><a class="dropdown-item" href="/unearth/advanced/drugs"><div class="icon-circle drugbank-icon icon-advanced"><svg class="icon" role="img" title="advanced">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#advanced"></use>
</svg>
</div> Advanced Search</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/spectra/ms/search"><div class="icon-circle drugbank-icon icon-ms"><svg class="icon" role="img" title="ms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#ms"></use>
</svg>
</div> MS Search</a><a class="dropdown-item" href="/spectra/ms_ms/search"><div class="icon-circle drugbank-icon icon-msms"><svg class="icon" role="img" title="msms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#msms"></use>
</svg>
</div> MS/MS Search</a><a class="dropdown-item" href="/spectra/c_ms/search"><div class="icon-circle drugbank-icon icon-gcms"><svg class="icon" role="img" title="gcms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#gcms"></use>
</svg>
</div> GC/MS Search</a><a class="dropdown-item" href="/spectra/nmr_one_d/search"><div class="icon-circle drugbank-icon icon-nmr-1d"><svg class="icon" role="img" title="nmr-1d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-1d"></use>
</svg>
</div> 1D NMR Search</a><a class="dropdown-item" href="/spectra/nmr_two_d/search"><div class="icon-circle drugbank-icon icon-nmr-2d"><svg class="icon" role="img" title="nmr-2d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-2d"></use>
</svg>
</div> 2D NMR Search</a></div></li><li class="nav-item"><a class="nav-link" href="/drug-interaction-checker">Interaction Checker</a></li><li class="nav-item"><a class="nav-link" href="/releases/latest">Downloads</a></li><li class="nav-item dropdown" role="presentation"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Solutions</a><div class="dropdown-menu"><div class="link-header dropdown-item">Products</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/clinical"><div class="icon-pink product-icon drugbank-icon icon-clinical"><svg class="icon" role="img" title="clinical"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#clinical"> </use></svg></div> Clinical Drug API</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/scientific"><div class="icon-pink product-icon drugbank-icon icon-scientific"><svg class="icon" role="img" title="scientific"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#scientific"> </use></svg></div> Scientific Drug Data</a><div class="link-header dropdown-item">Industries</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_discovery">Drug Discovery</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_repurposing">Drug Repurposing</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/precision_medicine">Precision Medicine</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/machine_learning">Machine Learning</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/telehealth">Telehealth</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/electronic_medical_records">Electronic Medical Records</a><div class="link-header dropdown-item">Resources</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/downloads">White Papers</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">About</a><div class="dropdown-menu right-menu"><div class="col-menu"><div class="menu-col"><div class="link-header dropdown-item"><a target="_blank" href="https://dev.drugbank.com/guides/index"><div class=" drugbank-icon icon-help_center"><svg class="icon" role="img" title="help_center"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#help_center"> </use></svg></div> Help Center</a></div><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/citing"><div class="icon-circle drugbank-icon icon-citing"><svg class="icon" role="img" title="citing">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#citing"></use>
</svg>
</div> Citing DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/faqs"><div class="icon-circle drugbank-icon icon-faq"><svg class="icon" role="img" title="faq">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#faq"></use>
</svg>
</div> DrugBank Online FAQs</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/searching"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> Searching DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/other_databases"><div class="icon-circle drugbank-icon icon-database"><svg class="icon" role="img" title="database">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#database"></use>
</svg>
</div> Other Databases</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/fields/drugs"><div class="icon-circle drugbank-icon icon-data-sources"><svg class="icon" role="img" title="data-sources">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#data-sources"></use>
</svg>
</div> Data Sources</a></div><div class="menu-col"><div class="link-header dropdown-item"><div class=" drugbank-icon icon-quick_link"><svg class="icon" role="img" title="quick_link"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#quick_link"> </use></svg></div> About</div><a class="dropdown-item" href="/about"><div class="icon-circle drugbank-icon icon-drugbank"><svg class="icon" role="img" title="drugbank">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugbank"></use>
</svg>
</div> About DrugBank Online</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/publications"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> DrugBank in Research</a><a class="dropdown-item" href="/stats"><div class="icon-circle drugbank-icon icon-statistics"><svg class="icon" role="img" title="statistics">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#statistics"></use>
</svg>
</div> Statistics</a><a class="dropdown-item" target="_blank" rel="noopener" href="https://blog.drugbank.com/"><div class="icon-circle drugbank-icon icon-news"><svg class="icon" role="img" title="news">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#news"></use>
</svg>
</div> Blog</a><a target="_blank" rel="noopener" class="dropdown-item" href="http://www.wishartlab.com"><div class="icon-circle drugbank-icon icon-wishart"><svg class="icon" role="img" title="wishart">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#wishart"></use>
</svg>
</div> Wishart Research Group</a><a class="dropdown-item" href="/contact"><div class="small-icon icon-circle drugbank-icon icon-paper-plane"><svg class="icon" role="img" title="paper-plane">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#paper-plane"></use>
</svg>
</div> Contact Us</a></div></div></div></li></ul></div></nav><nav class="navbar fixed-top navbar-expand search-bar justify-content-center justify-content-sm-end d-flex"><div class="form-container"><form class="form-inline" action="/unearth/q" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="search-group d-none d-sm-block" style="margin-right: 0.5rem;"><select name="searcher" id="searcher" class="form-control input-md"><option value="drugs">Drugs</option>
<option value="bio_entities">Targets</option>
<option value="pathways">Pathways</option>
<option value="indications">Indications</option></select> <div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> </div><div class="search-group"><input type="text" name="query" id="query" class="search-query"> <div class="drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> </div></form></div><div class="mini-banner banner-holder"><a target="_blank" href="https://blog.drugbank.com/trends-insights-research-spotlight-2021/"><div class="banner-text"><span class="mr-3">Discover published papers by academic researchers that use DrugBank data.</span><span class="banner-link"><span>Read Blog!</span><div class="icon-circle drugbank-icon icon-arrow-right"><svg class="icon" role="img" title="arrow-right">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-right"></use>
</svg>
</div></span></div></a><div class="close-banner"><div class="drugbank-icon icon-cross"><svg class="icon" role="img" title="cross">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#cross"></use>
</svg>
</div></div></div></nav></header><main role="main"><div class="content-container"><div class="content-header d-sm-flex align-items-center"><h1 class="align-self-center mr-auto">Pharmaco-metabolomics<small>Metabolite changes due to the metabolism of pharmaceutical compounds</small></h1><div class="page-actions ml-auto justify-content-sm-end mt-2 mt-sm-0"><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/genomics">Pharmaco-genomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1 disabled" href="/pharmaco/metabolomics">Pharmaco-metabolomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/transcriptomics">Pharmaco-transcriptomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/proteomics">Pharmaco-proteomics</a><a data-no-turbolink="true" class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/search">Search</a></div></div><form class="metabolite_regulation_search" id="metabolite_regulation_search" action="/pharmaco/metabolomics" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="container-fluid"><div class="filter-bar row justify-content-start d-flex flex-wrap flex-column flex-sm-row"><div class="advanced-toggle d-flex d-sm-none justify-content-between align-items-center"><h3>Advanced Filter</h3><div class="toggle"><div class="drugbank-icon icon-add"><svg class="icon" role="img" title="add">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#add"></use>
</svg>
</div><div class="drugbank-icon icon-subtract"><svg class="icon" role="img" title="subtract">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#subtract"></use>
</svg>
</div></div></div><div class="advanced-selector justify-content-start d-sm-flex flex-wrap flex-column flex-sm-row"><div class="group-selector d-sm-block"><h3>Filter by Group</h3><input value="or" type="hidden" name="q[g[0]][m]" id="q_g_0__m"><div class="form-check"><label class="button-control button-check-box" for="approved"><input name="q[g[0]][drug_approved_true]" type="hidden" value="all"><input class="button-control-input" id="approved" type="checkbox" value="1" name="q[g[0]][drug_approved_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Approved</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="nutraceutical"><input name="q[g[0]][drug_nutraceutical_true]" type="hidden" value="all"><input class="button-control-input" id="nutraceutical" type="checkbox" value="1" name="q[g[0]][drug_nutraceutical_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Nutraceutical</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="illicit"><input name="q[g[0]][drug_illicit_true]" type="hidden" value="all"><input class="button-control-input" id="illicit" type="checkbox" value="1" name="q[g[0]][drug_illicit_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Illicit</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="investigational"><input name="q[g[0]][drug_investigational_true]" type="hidden" value="all"><input class="button-control-input" id="investigational" type="checkbox" value="1" name="q[g[0]][drug_investigational_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Investigational</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="withdrawn"><input name="q[g[0]][drug_withdrawn_true]" type="hidden" value="all"><input class="button-control-input" id="withdrawn" type="checkbox" value="1" name="q[g[0]][drug_withdrawn_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Withdrawn</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="experimental"><input name="q[g[0]][drug_experimental_true]" type="hidden" value="all"><input class="button-control-input" id="experimental" type="checkbox" value="1" name="q[g[0]][drug_experimental_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Experimental</span></span></label></div></div><div class="availability-selector d-sm-block"><h3>Filter by Market Availability</h3><input value="or" type="hidden" name="q[g[1]][m]" id="q_g_1__m"><div class="form-check"><label class="button-control button-check-box" for="us"><input name="q[g[1]][drug_available_in_us_true]" type="hidden" value="all"><input class="button-control-input" id="us" type="checkbox" value="1" name="q[g[1]][drug_available_in_us_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">U.S.</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="ca"><input name="q[g[1]][drug_available_in_ca_true]" type="hidden" value="all"><input class="button-control-input" id="ca" type="checkbox" value="1" name="q[g[1]][drug_available_in_ca_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Canada</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="eu"><input name="q[g[1]][drug_available_in_eu_true]" type="hidden" value="all"><input class="button-control-input" id="eu" type="checkbox" value="1" name="q[g[1]][drug_available_in_eu_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">E.U.</span></span></label></div></div><div class="submit-filter ml-sm-auto pb-sm-0 justify-content-end d-sm-flex pt-2 align-items-end text-center"><div class="submit-buttons mt-2"><a class="btn btn-drugbank-secondary btn-sm mr-2" href="https://go.drugbank.com/pharmaco/metabolomics">Clear</a><input type="submit" name="commit" value="Apply Filter" class="btn btn-drugbank-primary btn-sm" data-disable-with="Apply Filter"></div></div></div></div></div><div class="index-content"><div class="pagination-holder"><div class="page_info">Displaying entries <b>2876 - 2900</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=115">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=113">113</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=114">114</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item active"><a remote="false" class="page-link">116</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=118">118</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=119">119</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=120">120</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=117">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div><table class="table-metabolite-regulations table table-bordered"><thead><tr><th>Drug</th><th>Drug Groups</th><th>Metabolite</th><th>Change</th><th>Description</th><th>Reference</th></tr><tr class="table-search-row"><th><input class=" form-control input-md input-tbl-search" type="text" name="q[drug_precise_names_name_cont]" id="q_drug_precise_names_name_cont"></th><th></th><th><input class=" form-control input-md input-tbl-search" type="text" name="q[metabolite_cont]" id="q_metabolite_cont"></th><th><select class=" form-control input-sm input-tbl-search select2-standard" name="q[change_eq]" id="q_change_eq"><option value=""></option>
<option value="increased">increased</option>
<option value="decreased">decreased</option></select></th><th></th><th class="table-search-submit"><div class="btn-group"><button name="button" type="submit" class="table-search-submit btn btn-sm btn-light"><div class="drugbank-icon icon-search-big"><svg class="icon" role="img" title="search-big">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search-big"></use>
</svg>
</div></button> <a id="table-search-reset" class="btn btn-light btn-sm" href="/pharmaco/metabolomics">Clear</a></div></th></tr></thead><tbody><tr><td><a href="/drugs/DB09389">Norgestrel</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Norgestrel <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24949" data-original-title="Blumel JE, Brandt A, Garabagno A, Cubillos M, Lozano A: [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies]. Rev Med Chil. 1990 Apr;118(4):382-7.">A24949</a></li></ul></td></tr><tr><td><a href="/drugs/DB09389">Norgestrel</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Norgestrel <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25364" data-original-title="Godsland IF: Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril. 2001 May;75(5):898-915.">A25364</a></li></ul></td></tr><tr><td><a href="/drugs/DB00335">Atenolol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>HDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Atenolol <em>decreases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26278" data-original-title="Satia MC, Shukla ML, Goyal RK: Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. Indian J Physiol Pharmacol. 1995 Jul;39(3):237-41.">A26278</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24966" data-original-title="Fagerberg B, Berglund A, Holme E, Wilhelmsen L, Elmfeldt D: Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol. J Intern Med. 1990 Jan;227(1):37-43.">A24966</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25086" data-original-title="Day JL, Metcalfe J, Simpson CN: Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1145-8.">A25086</a></li></ul></td></tr><tr><td><a href="/drugs/DB01039">Fenofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Fenofibrate <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25869" data-original-title="Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37.">A25869</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26276" data-original-title="Lilley JS, Linton MF, Fazio S: Oral retinoids and plasma lipids. Dermatol Ther. 2013 Sep-Oct;26(5):404-10. doi: 10.1111/dth.12085.">A26276</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25063" data-original-title="Tesone PA, Gladstein J, Acuna AM: Comparative study of bezafibrate and fenofibrate in patients with primary hyperlipoproteinaemia. Curr Med Res Opin. 1985;9(9):650-7.">A25063</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25870" data-original-title="Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995 Nov;18(11):621-9.">A25870</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25033" data-original-title="Hunninghake DB, Peters JR: Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med. 1987 Nov 27;83(5B):44-9.">A25033</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25655" data-original-title="McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619.">A25655</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25421" data-original-title="Bilz S, Wagner S, Schmitz M, Bedynek A, Keller U, Demant T: Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia. J Lipid Res. 2004 Jan;45(1):174-85. Epub 2003 Oct 1.">A25421</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26017" data-original-title="Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS: Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol. 2003 Aug;43(8):825-30.">A26017</a></li></ul></td></tr><tr><td><a href="/drugs/DB00684">Tobramycin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00562">Creatinine</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Tobramycin <em>increases</em> the level of <em>Creatinine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26313" data-original-title="Kuhlmann J, Seidel G, Grotsch H: Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity. Infection. 1982;10(4):233-9.">A26313</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26314" data-original-title="Ioannides-Demos LL, Li SC, Bastone EB, Spelman DW, Hooper RE, Cousins VC, McLean AJ: Absence of toxicity in patients with malignant otitis externa following long-term treatment with high dosage tobramycin. J Antimicrob Chemother. 1994 Aug;34(2):267-74.">A26314</a></li></ul><ul class="list-unstyled table-list"><li><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d9670bd-c8ae-41ce-9479-bdf6ce16ef52">DailyMed</a></li></ul></td></tr><tr><td><a href="/drugs/DB09389">Norgestrel</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Cholesterol</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Norgestrel <em>decreases</em> the level of <em>Cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25097" data-original-title="Paterson ME, Sturdee DW, Moore B, Whitehead TP: The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women. Br J Obstet Gynaecol. 1980 Jul;87(7):552-60.">A25097</a></li></ul></td></tr><tr><td><a href="/drugs/DB00973">Ezetimibe</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Ezetimibe <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26262" data-original-title="Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP: Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003 Apr;24(8):729-41.">A26262</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25592" data-original-title="Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M, Uemura A, Yoshida S, Matsubara Y, Kani A, Hasegawa K, Hishida H, Ozaki Y: The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb. 2010 Feb;17(1):106-14. Epub 2010 Jan 14.">A25592</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26292" data-original-title="Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15.">A26292</a></li></ul></td></tr><tr><td><a href="/drugs/DB00262">Carmustine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00294">Urea</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Carmustine <em>increases</em> the level of <em>Urea</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25353" data-original-title="Kintzel PE: Anticancer drug-induced kidney disorders. Drug Saf. 2001 Jan;24(1):19-38.">A25353</a></li></ul></td></tr><tr><td><a href="/drugs/DB01105">Sibutramine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Illicit</span> <span class="badge badge-secondary badge-pill">Investigational</span> <span class="badge badge-secondary badge-pill">Withdrawn</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Sibutramine <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26315" data-original-title="Sabuncu T, Harma M, Harma M, Nazligul Y, Kilic F: Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertil Steril. 2003 Nov;80(5):1199-204.">A26315</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25481" data-original-title="Baranowska B, Wolinska-Witort E, Martynska L, Chmielowska M, Mazurczak-Pluta T, Boguradzka A, Baranowska-Bik A: Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. Neuro Endocrinol Lett. 2005 Dec;26(6):675-9.">A25481</a></li></ul></td></tr><tr><td><a href="/drugs/DB00248">Cabergoline</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Total cholesterol</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Cabergoline <em>decreases</em> the level of <em>Total cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25799" data-original-title="Schwetz V, Librizzi R, Trummer C, Theiler G, Stiegler C, Pieber TR, Obermayer-Pietsch B, Pilz S: Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas. Metab Brain Dis. 2017 Feb;32(1):155-161. doi: 10.1007/s11011-016-9882-2. Epub 2016 Aug 15.">A25799</a></li></ul></td></tr><tr><td><a href="/drugs/DB00503">Ritonavir</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00122">Glucose</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Ritonavir <em>increases</em> the level of <em>Glucose</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25672" data-original-title="Bigoloni A, Gianotti N, Spagnuolo V, Galli L, Nozza S, Cossarini F, Salpietro S, Carini E, Piatti P, Vinci C, Lazzarin A, Castagna A: Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens. AIDS. 2012 Sep 10;26(14):1837-40. doi: 10.1097/QAD.0b013e32835705dd.">A25672</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26316" data-original-title="Arathoon E, Schneider S, Baraldi E, Lim PL, Opravil M, Van De Casteele T, Lavreys L: Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS. Int J STD AIDS. 2013 Jan;24(1):12-7. doi: 10.1258/ijsa.2012.012120. Epub 2013 May 6.">A26316</a></li></ul></td></tr><tr><td><a href="/drugs/DB00973">Ezetimibe</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Ezetimibe <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26292" data-original-title="Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15.">A26292</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25592" data-original-title="Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M, Uemura A, Yoshida S, Matsubara Y, Kani A, Hasegawa K, Hishida H, Ozaki Y: The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb. 2010 Feb;17(1):106-14. Epub 2010 Jan 14.">A25592</a></li></ul></td></tr><tr><td><a href="/drugs/DB00636">Clofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Total cholesterol</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Clofibrate <em>decreases</em> the level of <em>Total cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24844" data-original-title="Stein EA, Heimann KW: Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. S Afr Med J. 1975 Jul 19;49(31):1252-6.">A24844</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26267" data-original-title="Oster P, Schlierf G, Lang PD, Mordasini R, Vollmar J: Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers. Pharmatherapeutica. 1985;4(5):267-77.">A26267</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25142" data-original-title="Lageder H: [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia]. Wien Klin Wochenschr. 1980 Feb 1;92(3):95-101.">A25142</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25033" data-original-title="Hunninghake DB, Peters JR: Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med. 1987 Nov 27;83(5B):44-9.">A25033</a></li></ul></td></tr><tr><td><a href="/drugs/DB00590">Doxazosin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Doxazosin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26302" data-original-title="Talseth T, Westlie L, Daae L: Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up. Am Heart J. 1991 Jan;121(1 Pt 2):280-5.">A26302</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24982" data-original-title="Grimm RH Jr: alpha 1-antagonists in the treatment of hypertension. Hypertension. 1989 May;13(5 Suppl):I131-6.">A24982</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24981" data-original-title="Krone W, Nagele H: Metabolic changes during antihypertensive therapies. J Hum Hypertens. 1989 Dec;3 Suppl 2:69-73; discussion 74.">A24981</a></li></ul></td></tr><tr><td><a href="/drugs/DB02300">Calcipotriol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB01903">1,25-dihydroxyvitamin D3</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Calcipotriol <em>decreases</em> the level of <em>1,25-dihydroxyvitamin D3</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25277" data-original-title="Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, Hutchinson PE: The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol. 1997 Dec;37(6):929-34.">A25277</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26317" data-original-title="Park SB, Suh DH, Youn JI: A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999 Jul-Aug;16(4):321-5.">A26317</a></li></ul></td></tr><tr><td><a href="/drugs/DB08887">Icosapent ethyl</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span> <span class="badge badge-secondary badge-pill">Nutraceutical</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Icosapent ethyl <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26318" data-original-title="Ballantyne CM, Bays HE, Philip S, Doyle RT Jr, Braeckman RA, Stirtan WG, Soni PN, Juliano RA: Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies. Atherosclerosis. 2016 Oct;253:81-87. doi: 10.1016/j.atherosclerosis.2016.08.005. Epub 2016 Aug 20.">A26318</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26319" data-original-title="Nelson SD, Munger MA: Icosapent ethyl for treatment of elevated triglyceride levels. Ann Pharmacother. 2013 Nov;47(11):1517-23. doi: 10.1177/1060028013504079. Epub 2013 Nov 5.">A26319</a></li></ul></td></tr><tr><td><a href="/drugs/DB00641">Simvastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Simvastatin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25397" data-original-title="Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M: Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov;47(5):672-84.">A25397</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25870" data-original-title="Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995 Nov;18(11):621-9.">A25870</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26320" data-original-title="Kehely A, MacMahon M, Barbir M, Wray R, Hunt BJ, Prescott RJ, Thompson GR: Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia. QJM. 1995 Jun;88(6):421-7.">A26320</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26230" data-original-title="Gavish D, Leibovitz E, Shapira I, Rubinstein A: Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety. J Intern Med. 2000 May;247(5):563-9.">A26230</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26269" data-original-title="Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B: Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Clin Ther. 1991 Jul-Aug;13(4):500-10.">A26269</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24962" data-original-title="Stuyt PM, Mol MJ, Stalenhoef AF, Demacker PN, Van 't Laar A: Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia). Am J Med. 1990 Jan;88(1N):42N-45N.">A24962</a></li></ul></td></tr><tr><td><a href="/drugs/DB00331">Metformin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00122">Glucose</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Metformin <em>decreases</em> the level of <em>Glucose</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26271" data-original-title="Krysiak R, Okrzesik J, Okopien B: Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities. Exp Clin Endocrinol Diabetes. 2015 Oct;123(9):561-6. doi: 10.1055/s-0035-1564073. Epub 2015 Sep 15.">A26271</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26321" data-original-title="Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000 Dec;49(12):2063-9.">A26321</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26068" data-original-title="Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA: Challenges related to glycemic control in type 2 Diabetes Mellitus patients. Curr Drug Metab. 2017 Jan 15.">A26068</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25849" data-original-title="Bays HE, Goldberg RB, Truitt KE, Jones MR: Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects. Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.">A25849</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24931" data-original-title="DeFronzo RA, Barzilai N, Simonson DC: Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1991 Dec;73(6):1294-301.">A24931</a></li></ul></td></tr><tr><td><a href="/drugs/DB06817">Raltegravir</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Total cholesterol</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Raltegravir <em>increases</em> the level of <em>Total cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26264" data-original-title="Quercia R, Roberts J, Martin-Carpenter L, Zala C: Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks. Clin Drug Investig. 2015 Mar;35(3):211-9. doi: 10.1007/s40261-014-0266-2.">A26264</a></li></ul></td></tr><tr><td><a href="/drugs/DB08930">Dolutegravir</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Dolutegravir <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26264" data-original-title="Quercia R, Roberts J, Martin-Carpenter L, Zala C: Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks. Clin Drug Investig. 2015 Mar;35(3):211-9. doi: 10.1007/s40261-014-0266-2.">A26264</a></li></ul></td></tr><tr><td><a href="/drugs/DB00334">Olanzapine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Cholesterol</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Olanzapine <em>increases</em> the level of <em>Cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26212" data-original-title="Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S: Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2.">A26212</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25696" data-original-title="Hu S, Yao M, Peterson BS, Xu D, Hu J, Tang J, Fan B, Liao Z, Yuan T, Li Y, Yue W, Wei N, Zhou W, Huang M, Xu Y: A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and beta-cell function in schizophrenic patients. Psychopharmacology (Berl). 2013 Nov;230(1):3-13. doi: 10.1007/s00213-013-3073-1. Epub 2013 Apr 5.">A25696</a></li></ul></td></tr><tr><td><a href="/drugs/DB00627">Niacin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span> <span class="badge badge-secondary badge-pill">Nutraceutical</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Niacin <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24963" data-original-title="Garg A, Grundy SM: Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA. 1990 Aug 8;264(6):723-6.">A24963</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25891" data-original-title="Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA: Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000 Sep 13;284(10):1263-70.">A25891</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26292" data-original-title="Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15.">A26292</a></li></ul></td></tr><tr><td><a href="/drugs/DB09070">Tibolone</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00742">Homocysteine</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Tibolone <em>decreases</em> the level of <em>Homocysteine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25425" data-original-title="Kaleli B, Yildirim B, Demir S, Alatas E: Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women. Acta Obstet Gynecol Scand. 2003 Dec;82(12):1107-11.">A25425</a></li></ul></td></tr><tr><td><a href="/drugs/DB00331">Metformin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00214">Ornithine</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Metformin <em>decreases</em> the level of <em>Ornithine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25794" data-original-title="Rotroff DM, Oki NO, Liang X, Yee SW, Stocker SL, Corum DG, Meisner M, Fiehn O, Motsinger-Reif AA, Giacomini KM, Kaddurah-Daouk R: Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans. Front Pharmacol. 2016 Jun 14;7:135. doi: 10.3389/fphar.2016.00135. eCollection 2016.">A25794</a></li></ul></td></tr><tr><td><a href="/drugs/DB00641">Simvastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Simvastatin <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24944" data-original-title="Nakandakare E, Garcia RC, Rocha JC, Sperotto G, Oliveira HC, Quintao EC: Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins. Atherosclerosis. 1990 Dec;85(2-3):211-7.">A24944</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25870" data-original-title="Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995 Nov;18(11):621-9.">A25870</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26228" data-original-title="Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J: Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001 Dec 18;104(25):3046-51.">A26228</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26229" data-original-title="Stewart MW, Dyer RG, Alberti KG, Laker MF: The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia. Diabet Med. 1995 Mar;12(3):250-7.">A26229</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25424" data-original-title="Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, Ferri C: Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab. 2003 Nov;88(11):5341-7.">A25424</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26230" data-original-title="Gavish D, Leibovitz E, Shapira I, Rubinstein A: Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety. J Intern Med. 2000 May;247(5):563-9.">A26230</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26227" data-original-title="Panichi V, Mantuano E, Paoletti S, Santi S, Manca Rizza G, Cutrupi S, Pizzini P, Spoto B, Tripepi G, Zoccali C: Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. J Nephrol. 2008 Jan-Feb;21(1):38-44.">A26227</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25438" data-original-title="Skrha J, Stulc T, Hilgertova J, Weiserova H, Kvasnicka J, Ceska R: Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes. Eur J Pharmacol. 2004 Jun 16;493(1-3):183-9.">A25438</a></li></ul></td></tr></tbody></table><div class="pagination-holder"><div class="page_info">Displaying entries <b>2876 - 2900</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=115">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=113">113</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=114">114</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item active"><a remote="false" class="page-link">116</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=118">118</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=119">119</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=120">120</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=117">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div></div></form></div></main><footer><div class="row p-3 p-sm-4 m-0"><div class="col-md-5 footer-content"><div class="footer-item footer-commercial hidden"><img style="width: 130px; height: 100px;" src="/assets/plus/Data_Pink-68da9b7525141f098e2e0ebcbd888ce950fe6032fd0da3a227c22117cedd7062.png" alt="Data pink"><h2>Interested in using DrugBank in a <strong>commercial product</strong> or <strong>application?</strong></h2><a class="btn btn-pink-filled" target="_blank" href="https://www.drugbank.com/">Visit DrugBank.com <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#see_more"> </use></svg></div></a></div><div class="footer-item footer-newsletter" id="newsletter-1"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2>Stay up-to-date with the <br><strong>latest from DrugBank!</strong></h2></div><form action="https://dev.drugbank.com/contacts" class="form" id="newsletter-form" method="post"><input class="form-control hidden" id="contact_name" name="contact[name]" type="hidden" value="New Subscriber"><input class="form-control hidden" id="contact_mailing_list" name="contact[mailing_list]" type="hidden" value="yes"><input class="form-control hidden" id="data_type" name="data_type" type="hidden" value="json"><input class="form-control hidden" id="contact_address" name="contact[address]" type="hidden"><input class="form-control hidden" name="contact[return_url]" type="hidden" value="https://go.drugbank.com/#newsletter-3"><input class="form-control hidden" name="contact[form_url]" type="hidden" value="https://go.drugbank.com/"><input class="form-control hidden" id="referer" name="contact[referer]" type="hidden" value=""><input class="form-control hidden" id="type" name="contact[type]" type="hidden" value="newsletter"><input class="form-control hidden" id="ga_client_id" name="contact[ga_client_id]" type="hidden" value="1407225613.1636197853"><div class="input-group"><input class="form-control" id="contact_email" name="contact[email]" placeholder="Enter your email" required="" type="text"><span class="input-group-btn"><button class="btn btn-pink-filled" id="subscribe" type="submit">Subscribe</button></span></div><div class="help-block with-errors"></div></form></div><div class="footer-item footer-newsletter hidden" id="newsletter-3"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2><strong>Thank you</strong> <br>for subscribing!</h2></div></div></div><div class="col-md-7 footer-links"><div class="container"><div class="row footer-row"><div class="col-sm-4 footer-col"><div class="footer-header">About</div><div class="footer-list"><ul class="list-unstyled"><li><a href="/about">About DrugBank Online</a></li><li><a target="_blank" href="https://blog.drugbank.com/">Blog</a></li><li><a target="_blank" href="http://www.wishartlab.com">Wishart Research Group</a></li><li><a href="https://www.drugbank.com/about/careers">Careers</a></li><li><a href="/legal/terms_of_use">Terms of Use</a></li><li><a href="/legal/privacy_policy">Privacy Policy</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header">Support</div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://dev.drugbank.com/guides/index">Help Center</a></li><li><a target="_blank" href="https://dev.drugbank.com/guides/faqs">DrugBank Online FAQs</a></li><li><a href="/contact">Contact Support</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header"><a href="https://www.drugbank.com/">Commercial Data</a></div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://www.drugbank.com/clinical">Clinical Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/scientific">Scientific Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/contact/sales?ref=go.drugbank.com%2Fpharmaco%2Fmetabolomics">Contact Sales</a></li></ul></div></div></div><div class="row footer-row"><div class="col-sm-12"><div class="social-media"><a class="social-media-link" href="https://www.linkedin.com/company/drugbank/"><div class="drugbank-icon icon-linkedin"><svg class="icon" role="img" title="linkedin">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#linkedin"></use>
</svg>
</div></a><a class="social-media-link" href="https://twitter.com/DrugBankDB"><div class="drugbank-icon icon-twitter"><svg class="icon" role="img" title="twitter">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#twitter"></use>
</svg>
</div></a><a class="social-media-link" href="https://www.facebook.com/DrugBankDatabase"><div class="drugbank-icon icon-facebook"><svg class="icon" role="img" title="facebook">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#facebook"></use>
</svg>
</div></a></div><h6>Website design by Educe Design & Innovation Inc.</h6></div></div></div></div></div></footer><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon="{"rayId":"6a9e143659c26283","token":"e28ec36f07f74c1ca13c169ca4430981","version":"2021.10.0","si":100}"></script>
<script src="/assets/analytics-1b5960c76af2e5f1a83c45e21ee367baf13121e0a2d42380a71abadf0edaa402.js" media="all" data-turbolinks-track="true"></script><script type="text/javascript" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/2224137.js"></script></body></html>